Publications in collaboration with researchers from Mayo Clinic (4)

2023

  1. Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study

    European Urology, Vol. 84, Núm. 3, pp. 321-330

2021

  1. Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

    Journal of Clinical Oncology, Vol. 39, Núm. 33, pp. 3725-3736

2013

  1. Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: A subgroup analysis of the phase III RADIANT-2 study

    Oncologist, Vol. 18, Núm. 1, pp. 46-53

2011

  1. Therapy innovations: Tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors

    Cancer and Metastasis Reviews, Vol. 30, Núm. SUPPL. 1